{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:23:28Z","timestamp":1777141408404,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacig.2024.100338","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T01:17:49Z","timestamp":1725153469000},"page":"100338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence of cardiovascular events in a population-based Danish cohort with atopic dermatitis"],"prefix":"10.1016","volume":"3","author":[{"given":"Alexander","family":"Egeberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-1341","authenticated-orcid":false,"given":"Adina R.","family":"Lemeshow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shefali","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100338_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cjca.2010.12.040","article-title":"Chronic inflammatory diseases and cardiovascular risk: a systematic review","volume":"27","author":"Roifman","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacig.2024.100338_bib2","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and cardiovascular risk: a comprehensive review","volume":"37","author":"Masson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacig.2024.100338_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacig.2024.100338_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2024.100338_bib5","doi-asserted-by":"crossref","DOI":"10.5070\/D3258045124","article-title":"The prevalence of atopic dermatitis in adults: systematic review on population studies","author":"Mathiesen","year":"2019","journal-title":"Dermatol Online"},{"key":"10.1016\/j.jacig.2024.100338_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2340\/00015555-1761","article-title":"Is adult atopic eczema more common than we think? - a population-based study in Danish adults","volume":"94","author":"Vinding","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jacig.2024.100338_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2222.2007.02679.x","article-title":"Eczema, atopy and allergen exposure in adults: a population-based study","volume":"37","author":"Harrop","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2024.100338_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the National Eczema Association","volume":"137","author":"Drucker","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/all.13231","article-title":"Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide","volume":"73","author":"Thyssen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2024.100338_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2024.100338_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2014.11.023","article-title":"Eczema and cardiovascular risk factors in 2 US adult population studies","volume":"135","author":"Silverberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bjd\/ljad072","article-title":"Malignancy risk in patients with atopic dermatitis: a population-based cohort study","volume":"189","author":"Wan","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacig.2024.100338_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jacig.2024.100338_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.coph.2009.06.020","article-title":"Inflammation and cancer: how friendly is the relationship for cancer patients?","volume":"9","author":"Aggarwal","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jacig.2024.100338_bib19","first-page":"98","article-title":"Chronic inflammation in cancer development","volume":"2","author":"Multhoff","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamadermatol.2020.1948","article-title":"Association between atopic eczema and cancer in England and Denmark","volume":"156","author":"Mansfield","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018530","article-title":"Association between atopic dermatitis and colorectal cancer risk: a nationwide cohort study","volume":"99","author":"Chou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacig.2024.100338_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071172","article-title":"Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study","volume":"13","author":"Hedderson","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacig.2024.100338_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anai.2017.10.039","article-title":"Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape","volume":"120","author":"Boguniewicz","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2024.100338_bib24","unstructured":"Cibinqo 50 mg film-coated tablets (SmPC). Pfizer Europe: Brussels, Belgium; 2024."},{"key":"10.1016\/j.jacig.2024.100338_bib25","unstructured":"Olumiant 1 mg film-coated tablets (SmPC). Eli Lilly Nederland B.V: Utrecht, the Netherlands; 2023."},{"key":"10.1016\/j.jacig.2024.100338_bib26","unstructured":"Rinvoq 15 mg prolonged-release tablets (SmPC). AbbVie Logistics B.V.: Zwolle, the Netherlands; 2023."},{"key":"10.1016\/j.jacig.2024.100338_bib27","unstructured":"Dupixent 300 mg solution for injection in pre-filled syringe (SmPC). Sanofi Winthrop Industrie: Gentilly, France; 2024."},{"key":"10.1016\/j.jacig.2024.100338_bib28","unstructured":"Ebglyss 250 mg solution for injection in pre-filled syringe (SmPC). Almirall: Barcelona, Spain; 2023."},{"key":"10.1016\/j.jacig.2024.100338_bib29","series-title":"Adtralza 150 mg solution for injection in pre-filled syringe (SmPC)","year":"2023"},{"key":"10.1016\/j.jacig.2024.100338_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2017.06.042","article-title":"When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council","volume":"77","author":"Simpson","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib31","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/jdv.19255","article-title":"A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis","volume":"37","author":"Wollenberg","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jacig.2024.100338_bib32","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2023.08.102","article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jamadermatol.2023.1300","article-title":"Risk of venous thromboembolism among adults with atopic dermatitis","volume":"159","author":"Chen","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277469","article-title":"Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: a retrospective cohort study","volume":"17","author":"Hedderson","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacig.2024.100338_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s13555-021-00538-4","article-title":"Risk of venous thromboembolism among patients with atopic dermatitis: a cohort study in a US administrative claims database","volume":"11","author":"Meyers","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jacig.2024.100338_bib36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s12325-023-02445-w","article-title":"Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications","volume":"40","author":"Taylor","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacig.2024.100338_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100338_bib39","first-page":"1","article-title":"Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases","author":"Salinas","year":"2022","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jacig.2024.100338_bib41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jaad.2016.02.1227","article-title":"Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis","volume":"75","author":"Egeberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jacig.2024.100338_bib42","article-title":"Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study","volume":"6","author":"Aglehoff","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jacig.2024.100338_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:50:08Z","timestamp":1731347408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772829324001346"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100338","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of cardiovascular events in a population-based Danish cohort with atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100338"}}